Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

16.07
Delayed Data
As of Feb 11
 +0.60 / +3.88%
Today’s Change
13.27
Today|||52-Week Range
33.74
-11.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues194.6M32.2M94.5M104.9M
 
 
 
 
 
Cost of Goods Sold2.8M2.7M22.3M20.3M
 
 
 
 
 
Depreciation And Amortization3.0M3.0M27.3M27.6M
 
 
 
 
 
 
Operating ExpensesGross Income188.8M26.6M44.9M56.9M
 
 
 
 
 
General Expenses31.0M37.9M53.9M44.7M
 
 
 
 
 
Research And Development2.0M1.9M4.7M4.6M
 
 
 
 
 
Total Operating Expenses36.8M43.6M103.5M92.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income157.8M-11.4M-9.0M12.2M
 
 
 
 
 
Extraordinary Credit--1.8M1.3M830.0K
 
 
 
 
Extraordinary Charge---686.0K-10.2M-10.4M
 
 
 
 
Interest Expense On Debt6.1M5.6M21.4M22.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income151.8M-15.8M-39.2M-19.3M
 
 
 
 
 
Income Taxes-57.2M-4.2M-17.6M-7.6M
 
 
 
 
 
Net Income94.6M-11.6M-21.7M-11.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS58.9M59.6M60.0M60.3M
 
 
 
 
 
Shares To Calculate EPS Diluted79.4M59.6M60.0M60.3M
 
 
 
 
 
 
Earnings Per ShareEPS$1.23-$0.20-$0.36-$0.20
 
 
 
 
 
EPS Diluted$1.23-$0.20-$0.36-$0.20